XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Shares [Member]
Treasury Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Gain/(Loss) [Member]
Beginning balance at Dec. 31, 2023 $ 1,882,803 $ 2,497 $ (62) $ 2,878,155 $ (999,700) $ 1,913
Beginning balance, Shares at Dec. 31, 2023   80,044,378        
Treasury stock, Beginning balance (in shares) at Dec. 31, 2023     170,316      
Issuance of common shares, net of issuance costs 277,147 $ 132   277,015    
Issuance of common shares, net of issuance costs (in shares)   3,929,610        
Vesting of restricted shares 7 $ 7        
Vesting of restricted shares (in shares)   214,913        
Exercise of vested options, net of issuance costs 23,866 $ 22   23,844    
Exercise of vested options, net of issuance costs (in shares)   632,683        
Purchase of common stock under ESPP 764     764    
Purchase of common stock under ESPP (in shares)   16,026        
Stock-based compensation expense 19,405     19,405    
Other comprehensive income (loss) (3,465)         (3,465)
Net Income (Loss) (116,591)       (116,591)  
Ending balance at Mar. 31, 2024 2,083,936 $ 2,658 $ (62) 3,199,183 (1,116,291) (1,552)
Treasury Stock, Ending balance (in shares) at Mar. 31, 2024     170,316      
Ending balance, Shares at Mar. 31, 2024   84,837,610        
Beginning balance at Dec. 31, 2024 $ 1,932,080 $ 2,698 $ (62) 3,293,556 (1,365,952) 1,840
Beginning balance, Shares at Dec. 31, 2024   85,741,981        
Treasury stock, Beginning balance (in shares) at Dec. 31, 2024 170,316   170,316      
Issuance of common shares, net of issuance costs $ 8,637 $ 5   8,632    
Issuance of common shares, net of issuance costs (in shares)   162,482        
Vesting of restricted shares 15 $ 15        
Vesting of restricted shares (in shares)   396,943        
Exercise of vested options, net of issuance costs $ 1,264 $ 3   1,261    
Exercise of vested options, net of issuance costs (in shares) 39,996 39,996        
Purchase of common stock under ESPP $ 653     653    
Purchase of common stock under ESPP (in shares)   19,522        
Stock-based compensation expense 20,212     20,212    
Other comprehensive income (loss) 2,295         2,295
Net Income (Loss) (135,996)       (135,996)  
Ending balance at Mar. 31, 2025 $ 1,829,160 $ 2,721 $ (62) $ 3,324,314 $ (1,501,948) $ 4,135
Treasury Stock, Ending balance (in shares) at Mar. 31, 2025 170,316   170,316      
Ending balance, Shares at Mar. 31, 2025   86,360,924